Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Transrectal ultrasound (TRUS) biopsy
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Isotope bone scan

• Treatment Facilities:
• Radical prostatectomy
• External beam radiotherapy (EBRT)
• Chemotherapy

• Support Service Facilities:
• Clinical Nurse Specialist (CNS) in all clinics
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services
• Psychological counselling
• Genetic counselling

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	678	678
Performance Status recorded	100%	100%
PSA completed	87%	87%
Gleason Score completed	87%	87%
TNM completed	39%	39%
Risk group assigned	96%	96%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men with disease status determined	659	39897
Percentage of men diagnosed with metastatic disease	18%	17%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men diagnosed with low-risk localised disease	108	4684
Percentage of men with low-risk localised disease receiving radical treatment	12%	8%
No. of men diagnosed with locally advanced disease	246	15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment	80%	68%

	Treatment Centre
No. of men who received radical prostatectomy (April 2022- March 2023)	40
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	11%
No. of men who received radical prostatectomy (September 2020 - August 2021)	42
Adjusted percentage of men experiencing at least one GU complication (%)	8%
No. of men who received radical radiotherapy (September 2020 - August 2021)	133
Adjusted percentage of men experiencing at least one GI complication (%)	8%